Max Healthcare Institute (NSE:MAXHEALTH) Beneish M-Score: -2.32 (As of Jul. 01, 2026)


NSE:MAXHEALTH Max Healthcare Institute Ltd NSE:MAXHEALTH
90 GF Score
Price ₹1,129.25
GF Value ₹1,420.80
Valuation Modestly Undervalued
! 2 Warning Signs
View Full Analysis

What is Max Healthcare Institute Beneish M-Score?

Max Healthcare Institute NSE:MAXHEALTH -1.80% 90 Beneish M-Score is -2.32 as of Jul. 01, 2026. GuruFocus rates NSE:MAXHEALTH with a GF Score™ of 90/100 and a GF Value™ of ₹1,420.80 (Modestly Undervalued). The stock has 2 warning signs investors should review. Among 630 Healthcare Providers & Services companies, Max Healthcare Institute ranks worse than 69.05% on this metric.

The zones of discrimination for M-Score is as such:

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator.
An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

Good Sign:

Beneish M-Score -2.32 no higher than -1.78, which implies that the company is unlikely to be a manipulator.

The historical rank and industry rank for Max Healthcare Institute's Beneish M-Score or its related term are showing as below:

NSE:MAXHEALTH' s Beneish M-Score Range Over the Past 10 Years
Min: -2.71   Med: -2.33   Max: -0.83
Current: -2.32

During the past 12 years, the highest Beneish M-Score of Max Healthcare Institute was -0.83. The lowest was -2.71. And the median was -2.33.


Max Healthcare Institute Beneish M-Score Historical Data

* Premium members only.

The historical data trend for Max Healthcare Institute's Beneish M-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Max Healthcare Institute Beneish M-Score Chart

Max Healthcare Institute Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Beneish M-Score
Get a 7-Day Free Trial Premium Member Only Premium Member Only -2.28 -2.71 -2.19 -2.34 -2.32

Max Healthcare Institute Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Beneish M-Score Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -2.34 0.00 0.00 0.00 -2.32

NSE:MAXHEALTH vs HCA, THC, DVA: Beneish M-Score Comparison

For the Medical Care Facilities subindustry, Max Healthcare Institute's Beneish M-Score, along with its competitors' market caps and Beneish M-Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Max Healthcare Institute Beneish M-Score vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Max Healthcare Institute's Beneish M-Score distribution charts can be found below:

* The bar in red indicates where Max Healthcare Institute's Beneish M-Score falls into.


NSE:MAXHEALTH
90GF Score
Max Healthcare Institute Ltd NSE:MAXHEALTH
Beneish M-Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Max Healthcare Institute Beneish M-Score Calculation

The M-score was created by Professor Messod Beneish. Instead of measuring the bankruptcy risk (Altman Z-Score) or business trend (Piotroski F-Score), M-score can be used to detect the risk of earnings manipulation. This is the original research paper on M-score.

The M-Score Variables:

The M-score of Max Healthcare Institute for today is based on a combination of the following eight different indices:

M=-4.84+0.92 * DSRI+0.528 * GMI+0.404 * AQI+0.892 * SGI+0.115 * DEPI
=-4.84+0.92 * 1.0727+0.528 * 1.0046+0.404 * 0.9559+0.892 * 1.1914+0.115 * 0.9415
-0.172 * SGAI+4.679 * TATA-0.327 * LVGI
-0.172 * 1.0211+4.679 * -0.011079-0.327 * 0.9954
=-2.32

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

This Year (Mar26) TTM:Last Year (Mar25) TTM:
Total Receivables was ₹9,698 Mil.
Revenue was ₹83,735 Mil.
Gross Profit was ₹65,834 Mil.
Total Current Assets was ₹19,448 Mil.
Total Assets was ₹172,309 Mil.
Property, Plant and Equipment(Net PPE) was ₹75,722 Mil.
Depreciation, Depletion and Amortization(DDA) was ₹4,465 Mil.
Selling, General, & Admin. Expense(SGA) was ₹17,940 Mil.
Total Current Liabilities was ₹21,869 Mil.
Long-Term Debt & Capital Lease Obligation was ₹29,780 Mil.
Net Income was ₹14,424 Mil.
Gross Profit was ₹0 Mil.
Cash Flow from Operations was ₹16,333 Mil.
Total Receivables was ₹7,588 Mil.
Revenue was ₹70,285 Mil.
Gross Profit was ₹55,514 Mil.
Total Current Assets was ₹15,926 Mil.
Total Assets was ₹152,145 Mil.
Property, Plant and Equipment(Net PPE) was ₹64,962 Mil.
Depreciation, Depletion and Amortization(DDA) was ₹3,594 Mil.
Selling, General, & Admin. Expense(SGA) was ₹14,747 Mil.
Total Current Liabilities was ₹18,138 Mil.
Long-Term Debt & Capital Lease Obligation was ₹27,676 Mil.




1. DSRI = Days Sales in Receivables Index

Measured as the ratio of Revenue in Total Receivables in year t to year t-1.

A large increase in DSR could be indicative of revenue inflation.

DSRI=(Receivables_t / Revenue_t) / (Receivables_t-1 / Revenue_t-1)
=(9697.5 / 83734.5) / (7588.1 / 70284.6)
=0.115812 / 0.107962
=1.0727

2. GMI = Gross Margin Index

Measured as the ratio of gross margin in year t-1 to gross margin in year t.

Gross margin has deteriorated when this index is above 1. A firm with poorer prospects is more likely to manipulate earnings.

GMI=GrossMargin_t-1 / GrossMargin_t
=(GrossProfit_t-1 / Revenue_t-1) / (GrossProfit_t / Revenue_t)
=(55514.1 / 70284.6) / (65834.3 / 83734.5)
=0.789847 / 0.786227
=1.0046

3. AQI = Asset Quality Index

AQI is the ratio of asset quality in year t to year t-1.

Asset quality is measured as the ratio of non-current assets other than Property, Plant and Equipment to Total Assets.

AQI=(1 - (CurrentAssets_t + PPE_t) / TotalAssets_t) / (1 - (CurrentAssets_t-1 + PPE_t-1) / TotalAssets_t-1)
=(1 - (19447.9 + 75722) / 172309.4) / (1 - (15925.7 + 64962.2) / 152144.8)
=0.44768 / 0.468349
=0.9559

4. SGI = Sales Growth Index

Ratio of Revenue in year t to sales in year t-1.

Sales growth is not itself a measure of manipulation. However, growth companies are likely to find themselves under pressure to manipulate in order to keep up appearances.

SGI=Sales_t / Sales_t-1
=Revenue_t / Revenue_t-1
=83734.5 / 70284.6
=1.1914

5. DEPI = Depreciation Index

Measured as the ratio of the rate of Depreciation, Depletion and Amortization in year t-1 to the corresponding rate in year t.

DEPI greater than 1 indicates that assets are being depreciated at a slower rate. This suggests that the firm might be revising useful asset life assumptions upwards, or adopting a new method that is income friendly.

DEPI=(Depreciation_t-1 / (Depreciaton_t-1 + PPE_t-1)) / (Depreciation_t / (Depreciaton_t + PPE_t))
=(3594.2 / (3594.2 + 64962.2)) / (4465.3 / (4465.3 + 75722))
=0.052427 / 0.055686
=0.9415

Note: If the Depreciation, Depletion and Amortization data is not available, we assume that the depreciation rate is constant and set the Depreciation Index to 1.

6. SGAI = Sales, General and Administrative expenses Index

The ratio of Selling, General, & Admin. Expense(SGA) to Sales in year t relative to year t-1.

SGA expenses index > 1 means that the company is becoming less efficient in generate sales.

SGAI=(SGA_t / Sales_t) / (SGA_t-1 /Sales_t-1)
=(17940.1 / 83734.5) / (14747 / 70284.6)
=0.21425 / 0.209818
=1.0211

7. LVGI = Leverage Index

The ratio of total debt to Total Assets in year t relative to yeat t-1.

An LVGI > 1 indicates an increase in leverage

LVGI=((LTD_t + CurrentLiabilities_t) / TotalAssets_t) / ((LTD_t-1 + CurrentLiabilities_t-1) / TotalAssets_t-1)
=((29779.8 + 21869.4) / 172309.4) / ((27676.1 + 18137.7) / 152144.8)
=0.299747 / 0.30112
=0.9954

8. TATA = Total Accruals to Total Assets

Total accruals calculated as the change in working capital accounts other than cash less depreciation.

TATA=(IncomefromContinuingOperations_t - CashFlowsfromOperations_t) / TotalAssets_t
=(NetIncome_t - NonOperatingIncome_t - CashFlowsfromOperations_t) / TotalAssets_t
=(14424.1 - 0 - 16333.2) / 172309.4
=-0.011079

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator. An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

Max Healthcare Institute has a M-score of -2.32 suggests that the company is unlikely to be a manipulator.

Frequently Asked Questions Learn more about Beneish M-Score →
What does a Beneish M-Score of -2.32 mean?
Max Healthcare Institute (NSE:MAXHEALTH) has a Beneish M-Score of -2.32 as of Jul. 01, 2026. The Beneish M-score measures the likelihood of earnings manipulation. View historical data on Max Healthcare Institute and its competitors. According to the industry distribution chart, Max Healthcare Institute ranks #435 out of 630 companies in the Healthcare Providers & Services industry, placing it in the top 69%.
Is Max Healthcare Institute's Beneish M-Score too high?
Max Healthcare Institute's current Beneish M-Score is -2.32. Based on the distribution chart, Max Healthcare Institute ranks #435 out of 630 companies in the Healthcare Providers & Services industry, which is below the industry midpoint. Overall, Max Healthcare Institute has a GF Score™ of 90/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Max Healthcare Institute's Beneish M-Score compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Max Healthcare Institute ranks #435 out of 630 companies for Beneish M-Score. This places Max Healthcare Institute in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Beneish M-Score for a Healthcare Providers & Services company?
A good Beneish M-Score depends on the Healthcare Providers & Services industry context. However, Beneish M-Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Beneish M-Score mean?
A high Beneish M-Score can signal that a stock is expensive relative to its fundamentals. The Beneish M-score measures the likelihood of earnings manipulation. View historical data on Max Healthcare Institute and its competitors. Max Healthcare Institute's current Beneish M-Score is -2.32. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Max Healthcare Institute stock overvalued right now?
Based on GuruFocus' analysis, Max Healthcare Institute (NSE:MAXHEALTH) is currently considered Modestly Undervalued. The stock's GF Value™ is ₹1,420.80, compared to a current price of ₹1,129.25 — trading 20.5% below its estimated fair value. The current Beneish M-Score is -2.32. Max Healthcare Institute's overall GF Score™ is 90/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Beneish M-Score calculated?
Beneish M-Score is calculated from a company's financial statements. For Max Healthcare Institute (NSE:MAXHEALTH), the current Beneish M-Score is -2.32 as of Jul. 01, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Max Healthcare Institute (NSE:MAXHEALTH) Overvalued in 2026?

Based on GuruFocus' analysis, Max Healthcare Institute stock appears to be undervalued. The current stock price of ₹1,129.25 is trading 20.5% below its estimated GF Value™ of ₹1,420.80. GuruFocus considers Max Healthcare Institute to be Modestly Undervalued.

Key valuation signals for NSE:MAXHEALTH:

  • Beneish M-Score: -2.32
  • GF Value™: ₹1,420.80 vs. price of ₹1,129.25 (20.5% below fair value)
  • GF Score™: 90/100 with 2 warning signs

No single metric tells the full story. See the NSE:MAXHEALTH stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Max Healthcare Institute Business Description

Other Exchanges 543220:India
Address Capital Cyberscape, Sector-59, 2nd Floor, Gurugram, HR, IND, 122 102
Max Healthcare Institute Ltd is a health care service provider. The company's facilities include third-party healthcare providers with whom the company has entered long-term service contracts for providing clinical, radiology, and pathology services. Its hospitals provide the full range of services through its Outpatient, Day Care, Emergency Room, and In-Patient departments to accommodate medical specialties such as orthopedics, internal medicine, general surgery, cardiac sciences, oncology, neurosciences, and obstetrics, as well as diagnostics. The group derives revenue from India.
90GF Score

Get the complete analysis for NSE:MAXHEALTH

Beneish M-Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹1,129.25
Price
₹1,420.80
GF Value